Abstract:Many approved drugs are pleiotropic: for example, statins, whose main cholesterol-lowering activity is complemented by anticancer and prodiabetogenic mechanisms involving poorly characterized genetic interaction networks. We investigated these using the Saccharomyces cerevisiae genetic model, where most genetic interactions known are limited to the statin-sensitive S288C genetic background. We therefore broadened our approach by investigating gene interactions to include two statin-resistant genetic backgrounds: UWOPS87-2421 and Y55. Networks were functionally focused by selection of HMG1 and BTS1 mevalonate pathway genes for detection of genetic interactions. Networks, multilayered by genetic background, were analyzed for key genes using network centrality (degree, betweenness, and closeness), pathway enrichment, functional community modules, and Gene Ontology. Specifically, we found modification genes related to dysregulated endocytosis and autophagic cell death. To translate results to human cells, human orthologues were searched for other drug targets, thus identifying candidates for synergistic anticancer bioactivity. IMPORTANCE Atorvastatin is a highly successful drug prescribed to lower cholesterol and prevent cardiovascular disease in millions of people. Though much of its effect comes from inhibiting a key enzyme in the cholesterol biosynthetic pathway, genes in this pathway interact with genes in other pathways, resulting in 15% of patients suffering painful muscular side effects and 50% having inadequate responses. Such multigenic complexity may be unraveled using gene networks assembled from overlapping pairs of genes that complement each other. We used the unique power of yeast genetics to construct genome-wide networks specific to atorvastatin bioactivity in three genetic backgrounds to represent the genetic variation and varying response to atorvastatin in human individuals. We then used algorithms to identify key genes and their associated FDA-approved drugs in the networks, which resulted in the distinction of drugs that may synergistically enhance the known anticancer activity of atorvastatin.

Allele-specific behavior of molecular networks: understanding small-molecule drug response in yeast.

Functional variomics and network perturbation: connecting genotype to phenotype in cancer

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

Chemogenomic profiling: identifying the functional interactions of small molecules in yeast

Mapping Chromosomal Instability Induced by Small-Molecular Therapeutics in a Yeast Model

A novel method of using Deep Belief Networks and genetic perturbation data to search for yeast signaling pathways

In silico Genetic Network Models for *Pre-clinical Drug Prioritization

Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models

Reconstructing the Regulatory Circuit of Cell Fate Determination in Yeast Mating Response

Functional Dissection of Regulatory Models Using Gene Expression Data of Deletion Mutants.

Exploring Drug Combinations in Genetic Interaction Network

A pleiotropic-epistatic entangelement model of drug response

A Toy Model for Cooperative Phenomena in Molecular Biology and the Utilization of Biochemical Applications of PNS in Genetic Applications

Network Analysis Reveals the Molecular Bases of Statin Pleiotropy That Vary with Genetic Background

Edgetic Perturbation Models of Human Inherited Disorders

Interaction of Genetic Variants Activates Latent Metabolic Pathways in Yeast

Stitching Together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation

Characterizing the genetic architecture of drug response using gene-context interaction methods

Quantitative Modeling of Dose–response and Drug Combination Based on Pathway Network

Systemic Similarity Analysis of Compatibility Drug-Induced Multiple Pathway Patterns in Vivo

Genome-Scale Metabolic Modeling Identifies Causal Reactions Mediated by SNP-SNP Interactions Influencing Yeast Sporulation